NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for December 2025, as well as quarterly volumes, estimated revenue capture, number of listings, and index statistics for the quarter ended December 31, 2025, on its Investor Relations website. A data sheet showing this information can be found at: https://ir.nasdaq.com/financials/volume-statistics About Nasdaq Nasdaq (Nasdaq: NDAQ) is a global technology company serving corporate clients, investment managers, b ...

Nasdaq, Inc. (NDAQ) is a leading financial services and technology company that operates stock exchanges and provides market data, analytics, financial technology tools, and listing services across global capital markets. The firm runs the NASDAQ Stock Market along with other U.S. exchanges. Headquartered in New York, Nasdaq has a market cap of $51.7 billion. Companies worth $10 billion or more are typically classified as “large-cap stocks,” and Nasdaq fits the label perfectly, with its market cap exceedi ...

Core Insights - Ribbon Communications Inc. is partnering with Aircall to deploy a suite of solutions in the AWS cloud, enhancing Aircall's global communications infrastructure and ensuring regulatory compliance [1][2][4] - Aircall is implementing several Ribbon solutions, including SBC SWe for voice network security, PSX for call routing, Analytics for network monitoring, and RAMP for application management [2] - The deployment on AWS provides Aircall with a cost-effective alternative to private data centers, enabling faster time-to-market and operational flexibility [3] Company Overview - Ribbon Communications specializes in real-time communications technology and IP optical networking solutions, serving service providers, enterprises, and critical infrastructure sectors globally [1][4] - The company focuses on modernizing networks to improve competitive positioning and business outcomes, offering a comprehensive portfolio of software-centric solutions, cloud-native offers, and security tools [4] Aircall Overview - Aircall is an integrated customer communications platform trusted by over 20,500 companies, unifying voice and digital channels into a seamless platform [5] - The platform offers one-click integrations with leading CRMs and over 250 business tools, utilizing AI-powered insights to enhance customer interactions [5] - Aircall has a global team of over 600 employees across nine offices, driving smarter conversations and measurable success for businesses [5]

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for November 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About NasdaqNasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. ...

Core Insights - IBM is a mega-cap stock with a market capitalization of $284.6 billion, providing a wide range of integrated solutions and services in the IT sector [1][2] - The company has shown strong performance in the stock market, with a 37.9% year-to-date increase and a 32.5% rise over the past 52 weeks, significantly outperforming the Dow Jones Industrials Average [4] Financial Performance - In Q3, IBM reported an adjusted EPS of $2.65, exceeding Wall Street's expectations of $2.44, and revenue of $16.3 billion, surpassing the forecast of $16.1 billion [6] - Over the past three months, IBM stock gained 25%, while the Dow Jones Industrials Average only gained 4.4% during the same period [3] Market Position and Trends - IBM's advancements in quantum computing, particularly the 120-qubit Quantum Nighthawk processor, are expected to drive future growth, aiming for quantum advantage by 2026 and fault-tolerant computing by 2029 [5] - The demand for AI and automation solutions is contributing to IBM's growth, with software annual recurring revenue (ARR) increasing by 12.2%, and the AI business exceeding $9.5 billion [5] Stock Performance - Despite a recent slip of 6.7% from its 52-week high of $324.90, IBM has been trading above its 200-day moving average for the past year, indicating a bullish trend [3][4] - The stock has also been above its 50-day moving average since mid-September, further confirming its positive momentum [4]

Core Insights - Numeric, an AI-driven accounting automation platform, has successfully raised $51 million in a Series B funding round led by IVP, with participation from various investors including Access Industries and Alkeon [1][2] - The total capital raised by Numeric now amounts to $89 million, which will be utilized to expand its product offerings for enterprise finance teams and transition towards a comprehensive data platform for finance departments [2][3] - The company is set to release additional products focused on automating accounting processes through 2026 and 2027, enhancing its operational capabilities by combining AI pattern recognition with deterministic programming [3][4] Product Development - Numeric's current core offerings include close management, analytics, and cash management, with a new cash management product already in use by clients such as Public.com and Brex [2][4] - The funding will accelerate Numeric's vision of transforming accounting from manual spreadsheet tasks to a real-time strategic function, as stated by CEO Parker Gilbert [4]

Repligen Conference Call Summary Company Overview - **Company**: Repligen (NasdaqGS:RGEN) - **Date**: November 11, 2025 - **Key Performance**: Achieved 18% organic growth in Q3, with all key product areas showing double-digit growth [1][2] Core Insights Financial Performance - **Q3 Results**: Non-COVID organic growth of 16% year-to-date [2] - **Operating Margins**: 14.2%, a decrease of 70 basis points [1] - **Earnings Beat**: Exceeded market expectations by $0.05 on the bottom line [1] Product Portfolio and Market Segments - **Diverse Portfolio**: Emphasized the broad and innovative product range, with analytics and protein franchises outperforming expectations [3] - **Market Recovery**: Notable recovery in biopharma and CDMO sectors, with small biotech showing a significant rebound in sales and orders [4] - **Emerging Biotech**: Defined as biotech companies without commercial products; funding increased to approximately $12 billion in Q3, up from $8.9 billion in Q2 [6] Geographic Insights - **China Market**: Primarily driven by established pharma companies rather than emerging biotech; order intake slowed due to inventory buildup [8][54] Growth Projections - **Filtration Outlook**: Expected growth of 10-12%, with a focus on fluid management and delays in order deliveries affecting projections [12][15] - **Chrome Segment**: Experienced significant growth due to successful conversions of big pharma customers [18] - **Protein Segment**: Transitioned to a more autonomous business model, with expectations for double-digit growth driven by custom and catalog resins [21][25] New Modalities and Future Opportunities - **New Modalities**: Positive outlook for new modalities, including cell therapy and antibody-drug conjugates, with a diversified portfolio mitigating risks from specific programs [28][29] - **Cell Therapy**: Strong demand anticipated, particularly for ATF technology, with plans to expand product offerings [32] Operational and Margin Considerations - **Operational Expenses**: Organic OpEx growth of 14%, with a target to align OpEx growth with top-line growth in the coming years [48][49] - **Margin Goals**: Aiming for 30% EBITDA by 2030 and mid-50s gross margin in the next few years [51][52] Strategic Initiatives - **Onshoring Trends**: Anticipated RFPs related to onshoring expected to emerge by mid-2026, presenting significant opportunities for bioprocessing companies [38][39] - **Hardware Growth**: Hardware revenue increased by 20%, with expectations for continued growth driven by differentiated product offerings [42] Conclusion - **Market Positioning**: Repligen aims to maintain a growth rate of 5% above market growth, leveraging its innovative portfolio and clinical exposure to drive demand [57][58]

Core Insights - Altus Group Limited reported steady growth in recurring revenue and an expansion in adjusted EBITDA margin for Q3 2025, indicating a positive financial trajectory [1][2]. Financial Performance - Revenue for Q3 2025 reached C$133.3 million, a 2.2% increase from C$128.4 million in Q3 2024 [2]. - Recurring revenue grew by 5.2% to C$102.4 million compared to C$95.4 million in the same quarter last year [2]. - Profit from continuing operations improved significantly to C$0.5 million from a loss of C$2.9 million, marking a 117.8% change [2]. - Adjusted EBITDA increased by 16.1% to C$25.6 million, with an adjusted EBITDA margin of 19.2%, up 230 basis points from 16.8% [2]. - Free cash flow rose by 36.5% to C$21.9 million, with free cash flow per share increasing by 45.7% to C$0.51 [2]. Business Outlook - The company provided guidance for Q4 2025, projecting 3-5% growth in total analytics revenue and 5-7% growth in recurring revenue [5]. - Adjusted EBITDA margin expansion is expected to be between 200-300 basis points for Q4 2025 [5]. - The full-year outlook for 2025 has been refined, now anticipating 2-4% growth in total analytics revenue and 4-6% growth in recurring revenue [5][6]. Dividend Information - The Board approved a cash dividend of C$0.15 per common share for Q4 2025, payable on January 15, 2026 [8]. Cash Flow and Financial Health - Net cash provided by operating activities for Q3 2025 was C$22.6 million, a 22.8% increase from C$18.4 million in Q3 2024 [2]. - The funded debt to EBITDA ratio improved to 1.21 from 2.07, indicating a stronger balance sheet [2]. Shareholder Information - The company’s Dividend Reinvestment Plan (DRIP) allows eligible shareholders to reinvest dividends into additional common shares at a discount [9]. Company Overview - Altus Group Limited specializes in providing commercial real estate intelligence, leveraging data and analytics to enhance performance and mitigate risks in the industry [12].

Core Viewpoint - Booz Allen Hamilton Holding Corporation (BAH) reported weak financial results for Q2 of fiscal 2026, leading to multiple analysts reducing their price targets for the stock [2][5]. Financial Performance - Revenue decreased by 8.1% year-over-year to $2.9 billion, while net income fell by 55.1% to $175 million compared to the same period last year [2]. - The company has revised its full-year outlook downward due to a "continued funding slowdown" [2]. Analyst Reactions - Stifel reduced its price target from $119 to $106 while maintaining a Hold rating, noting this was the second time in three months that management's outlook was worse than expected [3]. - Goldman Sachs lowered its price target from $93 to $80 and kept a Sell rating, citing weak financial performance and adverse effects from government funding re-prioritization [5]. - UBS also cut its price target from $115 to $93, maintaining a Neutral rating on the stock [6]. Market Environment - Analysts indicated that while the market environment for government services is not worsening, it remains far from normalizing for Booz Allen [4]. - There is ongoing volatility and uncertainty in the market, prompting analysts to favor stocks that are not experiencing similar declines [4][6].

Moving the world of Commerce forward October 2025 Forward-Looking Statements and Non-GAAP Financial Measures *Source: TAM Analysis and Market Penetration Study leveraging US Census NAICS Codes across Retail (42 Wholesalers), Distribution (42 Wholesalers), CPG/Finished Goods (31-33 Manufacturing), Retailers/Stores acting as suppliers (44-45 Retail Trade) as of February 2025. This presentation contains forward-looking statements, including information about management's view of SPS Commerce's future expectati ...